Florence, May 20, 2026
Hospitex International Srl, a company of the Aliko Scientific Group specializing in the development and production of advanced cytology solutions, has been awarded a major five-year public contract issued by the Federico II University Hospital in Naples.
The tender involves the supply of a diagnostic system and liquid-based cytology reagents for the Interdepartmental Program of Cytopathology and Predictive Molecular Pathology within the Department of Onco-Hematological Diseases, Pathological Anatomy, and Rheumatological Diseases.
The supply includes diagnostic instruments, consumables, and liquid-based cytology reagents, as well as technical assistance, full-risk maintenance, and ongoing operational support, within a model focused on service continuity and the generation of recurring revenue.
For Hospitex, this award represents further recognition of the quality and competitiveness of its cytology solutions, confirming its growing role within high-complexity Italian public healthcare facilities.
The Federico II University Hospital is recognized among the leading Italian university and clinical centers in the fields of oncology, pathological anatomy, molecular diagnostics, translational medicine, and advanced clinical research.
“This award represents a high-value result for Hospitex and confirms the solidity of our industrial and scientific path. Bringing our technologies to a reference university center like Federico II means making a concrete contribution to the evolution of cytological diagnostics, making it increasingly standardized, efficient, and integrated into care pathways,” stated Francesco Trisolini, CEO of Hospitex International.
The agreement is part of the Aliko Scientific Group‘s growth strategy, aimed at expanding the installed base, developing recurring models based on reagents, consumables, and services, and disseminating advanced diagnostic solutions for oncological pathology.
Through its Liquid-Based Cytology technology, Hospitex continues to support laboratories, hospitals, and reference centers in implementing more efficient, reproducible diagnostic processes focused on the quality of results.
